Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers.
Éva BartusGábor OlajosIldikó SchusterZsolt BozsóMária A DeliSzilvia VeszelkaFruzsina R WalterZsolt DatkiZsolt SzakonyiTamás A MartinekLivia FulopPublished in: Molecules (Basel, Switzerland) (2018)
Alzheimer's disease is one of the most common chronic neurodegenerative disorders. Despite several in vivo and clinical studies, the cause of the disease is poorly understood. Currently, amyloid β (Aβ) peptide and its tendency to assemble into soluble oligomers are known as a main pathogenic event leading to the interruption of synapses and brain degeneration. Targeting neurotoxic Aβ oligomers can help recognize the disease at an early stage or it can be a potential therapeutic approach. Unnatural β-peptidic foldamers are successfully used against many different protein targets due to their favorable structural and pharmacokinetic properties compared to small molecule or protein-like drug candidates. We have previously reported a tetravalent foldamer-dendrimer conjugate which can selectively bind Aβ oligomers. Taking advantage of multivalency and foldamers, we synthesized different multivalent foldamer-based conjugates to optimize the geometry of the ligand. Isothermal titration calorimetry (ITC) was used to measure binding affinity to Aβ, thereafter 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) based tissue viability assay and impedance-based viability assay on SH-SY5Y cells were applied to monitor Aβ toxicity and protective effects of the compounds. Important factors for high binding affinity were determined and a good correlation was found between influencing the valence and the capability of the conjugates for Aβ binding.
Keyphrases
- small molecule
- cancer therapy
- early stage
- binding protein
- drug delivery
- dna binding
- squamous cell carcinoma
- emergency department
- lymph node
- magnetic resonance imaging
- amino acid
- cell cycle arrest
- oxidative stress
- computed tomography
- cognitive decline
- magnetic resonance
- white matter
- signaling pathway
- cell death
- subarachnoid hemorrhage
- mass spectrometry
- cell proliferation
- resting state
- transcription factor
- single cell